Phillips-Medisize Corporation has added cold chain storage to its existing capabilities. The new systems will be added to the company’s Menomonie, Wis., medical campus to support new business and future growth.

Cold chain storage regularly is used in the drug delivery and pharmaceutical markets to support life sciences products that require storage and handling between 2 and 8 degrees Celsius (35.6 and 46.4 degrees Fahrenheit). To complement this new capability, Phillips-Medisize has created an on-site analytical testing capability to perform incoming and final release batch testing (and the standard operating procedures to go with it). The new cold chain storage system reportedly will be able to hold temperatures constant to within positive/negative 0.5 degrees Celsius. The system also has redundant compressors and a full generator back up system.

“The addition of cold chain storage is a direct reflection of our continued focus on meeting our customers’ needs by investing in our facilities, processes, and people to continue to deliver quality, service, and innovation,” said company President and CEO Matt Jennings.

The U.S. Food and Drug Administration-registered Menomonie facility will need to expand to accommodate the new cold storage system. Phillips-Medisize plans a 25,000-square-foot expansion including a Class 8 clean room assembly space and infrastructure to support finished goods assembly and packaging of drug delivery and combination devices. Once the expansion is complete, the facility will have more than 200,000 square feet of purpose-built Class 7 and 8 clean room space, and also will have dedicated molding clean rooms, device assembly clean rooms, and drug handling and packaging clean rooms. The expansion is expected to be completed by April 2013.

Phillips-Medisize Corporation is based in Hudson, Wis., and offers services such as design development, prototyping and testing to the medical device sector.